CANY
Caxton Associates (New York) Portfolio holdings
AUM
$3.14B
1-Year Return
47.7%
This Quarter Return
+7.19%
1 Year Return
+47.7%
3 Year Return
+76.82%
5 Year Return
+185.43%
10 Year Return
+401.35%
AUM
$880M
AUM Growth
-$121M
(-12%)
Cap. Flow
-$182M
Cap. Flow
% of AUM
-20.69%
Top 10 Holdings %
Top 10 Hldgs %
76.33%
Holding
578
New
146
Increased
49
Reduced
78
Closed
295
Top Buys
| 1 |
Equinor
EQNR
|
$30.9M |
| 2 |
Aptiv
APTV
|
$23.8M |
| 3 |
Coterra Energy
CTRA
|
$18.4M |
| 4 |
EQT Corp
EQT
|
$16.3M |
| 5 |
Altice USA
ATUS
|
$15.9M |
Top Sells
| 1 |
iShares Silver Trust
SLV
|
$28.9M |
| 2 |
Apple
AAPL
|
$23.1M |
| 3 |
SPDR Gold Trust
GLD
|
$20.3M |
| 4 |
Amazon
AMZN
|
$17M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$16.9M |
Sector Composition
| 1 | Energy | 16.1% |
| 2 | Technology | 10.77% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Communication Services | 3.82% |
| 5 | Healthcare | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
201
DELISTED
PDL BioPharma, Inc.
PDLI
| $275K | 0.03% |
+87,446
| New | +$275K |
|
202
Inspire Medical Systems
INSP
$2.56B
| $273K | 0.03% |
+2,118
| New | +$273K |
|
203
Emergent Biosolutions
EBS
$404M
| $272K | 0.03% |
2,637
-3,797
| -59% | -$392K |
|
204
Exelixis
EXEL
$10.2B
| $272K | 0.03% |
11,142
-2,965
| -21% | -$72.4K |
|
205
argenx
ARGX
$45.9B
| $266K | 0.03% |
+1,013
| New | +$266K |
|
206
ESCO Technologies
ESE
$5.23B
| $266K | 0.03% |
+3,299
| New | +$266K |
|
207
NIO
NIO
$13.4B
| $265K | 0.03% |
12,487
-13,143
| -51% | -$279K |
|
|
PACW
208
DELISTED
PacWest Bancorp
PACW
| $265K | 0.03% |
15,503
-339
| -2% | -$5.8K |
|
209
Match Group
MTCH
$9.18B
| $262K | 0.03% |
+2,369
| New | +$262K |
|
210
Factset
FDS
$14B
| $261K | 0.03% |
+778
| New | +$261K |
|
211
Okta
OKTA
$16.1B
| $259K | 0.03% |
1,210
-1,953
| -62% | -$418K |
|
212
Intel
INTC
$107B
| $256K | 0.03% |
4,937
-63,663
| -93% | -$3.3M |
|
213
Morgan Stanley
MS
$236B
| $256K | 0.03% |
+5,288
| New | +$256K |
|
|
ARNA
214
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $256K | 0.03% |
3,425
-1,218
| -26% | -$91K |
|
215
AppFolio
APPF
$10.2B
| $254K | 0.03% |
1,790
-3,948
| -69% | -$560K |
|
216
Zscaler
ZS
$42.7B
| $252K | 0.03% |
+1,788
| New | +$252K |
|
|
CIM
217
Chimera Investment
CIM
$1.2B
| $249K | 0.03% |
10,108
-572
| -5% | -$14.1K |
|
|
VAR
218
DELISTED
Varian Medical Systems, Inc.
VAR
| $249K | 0.03% |
+1,447
| New | +$249K |
|
219
Invesco Mortgage Capital
IVR
$529M
| $245K | 0.03% |
+9,059
| New | +$245K |
|
|
LHCG
220
DELISTED
LHC Group LLC
LHCG
| $245K | 0.03% |
+1,152
| New | +$245K |
|
221
Green Brick Partners
GRBK
$3.2B
| $241K | 0.03% |
+14,953
| New | +$241K |
|
222
Las Vegas Sands
LVS
$36.9B
| $240K | 0.03% |
+5,148
| New | +$240K |
|
223
Vornado Realty Trust
VNO
$7.93B
| $238K | 0.03% |
7,066
-1,542
| -18% | -$51.9K |
|
224
KORU Medical Systems
KRMD
$188M
| $237K | 0.02% |
32,782
-10,157
| -24% | -$73.4K |
|
225
Zoetis
ZTS
$67.9B
| $235K | 0.02% |
+1,419
| New | +$235K |
|